Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market – Video

Posted: September 20, 2014 at 6:42 am




Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market
HAIFA, Israel, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today it is evaluating...

By: CorporateProfile

Excerpt from:
Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market - Video

Related Posts

Comments are closed.

Archives